Cargando…

Comparison of gut microbiota in male MAFLD patients with varying liver stiffness

PURPOSE: In this study, we examined the changes to the composition and function of the gut microbiota from patients with metabolic dysfunction-associated fatty liver disease (MAFLD).We compared patients in a case group (liver stiffness (LSM) ≥ 7.4 kPa) with a matched control group (LSM < 7.4 kPa)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuheng, Yan, Su, Sheng, Shifeng, Qin, Qian, Chen, Jingfeng, Li, Weikang, Li, Tiantian, Gao, Xinxin, Wang, Lin, Ang, Li, Ding, Suying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381746/
https://www.ncbi.nlm.nih.gov/pubmed/35992168
http://dx.doi.org/10.3389/fcimb.2022.873048
_version_ 1784769142318956544
author Zhang, Yuheng
Yan, Su
Sheng, Shifeng
Qin, Qian
Chen, Jingfeng
Li, Weikang
Li, Tiantian
Gao, Xinxin
Wang, Lin
Ang, Li
Ding, Suying
author_facet Zhang, Yuheng
Yan, Su
Sheng, Shifeng
Qin, Qian
Chen, Jingfeng
Li, Weikang
Li, Tiantian
Gao, Xinxin
Wang, Lin
Ang, Li
Ding, Suying
author_sort Zhang, Yuheng
collection PubMed
description PURPOSE: In this study, we examined the changes to the composition and function of the gut microbiota from patients with metabolic dysfunction-associated fatty liver disease (MAFLD).We compared patients in a case group (liver stiffness (LSM) ≥ 7.4 kPa) with a matched control group (LSM < 7.4 kPa) and investigated the correlation between characteristics of the microbiota and other biochemical indicators. METHODS: The study looked at a total of 85 men with MAFLD, 17 of whom were in the case group and 68 of whom were in the control group. We measured waist circumference, blood pressure, and body mass index, as well as clinical parameters including liver stiffness, enzyme levels, cholesterol levels, and fat attenuation. Whole-genome shotgun sequencing technology and the MetaCyc database were then used to detect the composition and major pathways of the gut microbiota for each patient. Statistical analyses were performed, including the chi-square test, the student’s t-test, the Wilcoxon rank-sum test, and the Mann–Whitney test. RESULTS: Whole-genome sequencing showed that the composition of the gut microbiota in patients with an LSM of above 7.4 kPa was significantly different to that of the control group. There were seven bacterial species that were different between the two groups. Prevotella copri, Phascolarctobacterium succinatutens, Eubacterium biforme, and Collinsella aerofaciens were enriched in the case group (P < 0.05). Conversely, Bacteroides coprocola, Bacteroides stercoris and Clostridiales bacterium 1_7_47FAA were decreased in the case group (P < 0.05). Furthermore, after removing low abundance pathways, a total of 32 microbial pathways were found to be significantly different between the two groups. Most pathways enriched in the case group over the control were related to biosynthesis of metabolites including amino acids, vitamins, nucleosides, and nucleotides. Conclusion. The composition and function of the gut microbiota in patients with increased liver stiffness are significantly altered. This observation may provide new avenues to better understand the mechanism of liver fibrosis.
format Online
Article
Text
id pubmed-9381746
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93817462022-08-18 Comparison of gut microbiota in male MAFLD patients with varying liver stiffness Zhang, Yuheng Yan, Su Sheng, Shifeng Qin, Qian Chen, Jingfeng Li, Weikang Li, Tiantian Gao, Xinxin Wang, Lin Ang, Li Ding, Suying Front Cell Infect Microbiol Cellular and Infection Microbiology PURPOSE: In this study, we examined the changes to the composition and function of the gut microbiota from patients with metabolic dysfunction-associated fatty liver disease (MAFLD).We compared patients in a case group (liver stiffness (LSM) ≥ 7.4 kPa) with a matched control group (LSM < 7.4 kPa) and investigated the correlation between characteristics of the microbiota and other biochemical indicators. METHODS: The study looked at a total of 85 men with MAFLD, 17 of whom were in the case group and 68 of whom were in the control group. We measured waist circumference, blood pressure, and body mass index, as well as clinical parameters including liver stiffness, enzyme levels, cholesterol levels, and fat attenuation. Whole-genome shotgun sequencing technology and the MetaCyc database were then used to detect the composition and major pathways of the gut microbiota for each patient. Statistical analyses were performed, including the chi-square test, the student’s t-test, the Wilcoxon rank-sum test, and the Mann–Whitney test. RESULTS: Whole-genome sequencing showed that the composition of the gut microbiota in patients with an LSM of above 7.4 kPa was significantly different to that of the control group. There were seven bacterial species that were different between the two groups. Prevotella copri, Phascolarctobacterium succinatutens, Eubacterium biforme, and Collinsella aerofaciens were enriched in the case group (P < 0.05). Conversely, Bacteroides coprocola, Bacteroides stercoris and Clostridiales bacterium 1_7_47FAA were decreased in the case group (P < 0.05). Furthermore, after removing low abundance pathways, a total of 32 microbial pathways were found to be significantly different between the two groups. Most pathways enriched in the case group over the control were related to biosynthesis of metabolites including amino acids, vitamins, nucleosides, and nucleotides. Conclusion. The composition and function of the gut microbiota in patients with increased liver stiffness are significantly altered. This observation may provide new avenues to better understand the mechanism of liver fibrosis. Frontiers Media S.A. 2022-08-03 /pmc/articles/PMC9381746/ /pubmed/35992168 http://dx.doi.org/10.3389/fcimb.2022.873048 Text en Copyright © 2022 Zhang, Yan, Sheng, Qin, Chen, Li, Li, Gao, Wang, Ang and Ding https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Zhang, Yuheng
Yan, Su
Sheng, Shifeng
Qin, Qian
Chen, Jingfeng
Li, Weikang
Li, Tiantian
Gao, Xinxin
Wang, Lin
Ang, Li
Ding, Suying
Comparison of gut microbiota in male MAFLD patients with varying liver stiffness
title Comparison of gut microbiota in male MAFLD patients with varying liver stiffness
title_full Comparison of gut microbiota in male MAFLD patients with varying liver stiffness
title_fullStr Comparison of gut microbiota in male MAFLD patients with varying liver stiffness
title_full_unstemmed Comparison of gut microbiota in male MAFLD patients with varying liver stiffness
title_short Comparison of gut microbiota in male MAFLD patients with varying liver stiffness
title_sort comparison of gut microbiota in male mafld patients with varying liver stiffness
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381746/
https://www.ncbi.nlm.nih.gov/pubmed/35992168
http://dx.doi.org/10.3389/fcimb.2022.873048
work_keys_str_mv AT zhangyuheng comparisonofgutmicrobiotainmalemafldpatientswithvaryingliverstiffness
AT yansu comparisonofgutmicrobiotainmalemafldpatientswithvaryingliverstiffness
AT shengshifeng comparisonofgutmicrobiotainmalemafldpatientswithvaryingliverstiffness
AT qinqian comparisonofgutmicrobiotainmalemafldpatientswithvaryingliverstiffness
AT chenjingfeng comparisonofgutmicrobiotainmalemafldpatientswithvaryingliverstiffness
AT liweikang comparisonofgutmicrobiotainmalemafldpatientswithvaryingliverstiffness
AT litiantian comparisonofgutmicrobiotainmalemafldpatientswithvaryingliverstiffness
AT gaoxinxin comparisonofgutmicrobiotainmalemafldpatientswithvaryingliverstiffness
AT wanglin comparisonofgutmicrobiotainmalemafldpatientswithvaryingliverstiffness
AT angli comparisonofgutmicrobiotainmalemafldpatientswithvaryingliverstiffness
AT dingsuying comparisonofgutmicrobiotainmalemafldpatientswithvaryingliverstiffness